Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion type Assertion NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_head.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion description "[We genotyped 84 patients, 28 patients with grade 3 or 4 leukopenia/neutropenia, and 56 with no toxicity (patients with grade 1 or 2 were excluded), for a total of 79 single nucleotide polymorphisms (SNPs) in seven genes possibly involved in the metabolism or transport of this drug: CYP3A4, CYP3A5, ABCB1, ABCC2, SLCO1B3, NR1I2, and NR1I3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_provenance.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion evidence source_evidence_literature NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_provenance.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion SIO_000772 18294295 NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_provenance.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion wasDerivedFrom gad-20150221 NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_provenance.
- NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_assertion wasGeneratedBy ECO_0000203 NP111491.RA9ynpsxiBfkltuLcqXwU2AVE7ou6N_477LwW5U2tzdeA130_provenance.